Boston Scientific (BSX) shares look ready to make a big move out above the 2020 and 2021 highs after consolidating in a multi-week flag under $45.50. Shares are clearing the 8- and 21-EMA this week and just below a downtrend from the August highs. BSX has shown some relative strength since late December and MACD/RSI has reset a bit but remains bullish. April begins a strong seasonal push for the stock too with three of the last four years higher and an average 7.5% move close.